Mucosolvan 1x Täglich (Ambroxol Hydrochloride)

Ambroxol Hydrochloride, the active ingredient in Mucosolvan 1x Täglich, is a mucolytic presented as an oral tablet for oral use. It facilitates the breakdown of thick bronchial mucus and is employed to improve clearance of secretions in patients with acute or chronic respiratory conditions such as bronchitis and COPD.

GNH USA supplies Mucosolvan 1x Täglich as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU quality standards, is manufactured under strict GMP conditions, and is available for bulk distribution.

Ambroxol Hydrochloride acts as a mucolytic on the respiratory tract, helping to thin and mobilize mucus in several common pulmonary conditions.

Acute bronchitis: reduces mucus viscosity, facilitating expectoration and relieving cough. Chronic bronchitis: improves mucus clearance, decreasing frequency of productive cough episodes. COPD with productive cough: aids in thinning secretions, supporting airway patency and symptom control. Upper respiratory tract infections with thick mucus: promotes drainage of nasal and bronchial secretions, easing congestion.

Ambroxol Hydrochloride may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Taste alteration: a temporary bitter or metallic taste in the mouth. - Nausea: mild stomach upset after oral administration. - Diarrhea: loose stools occurring shortly after dosing. - Headache: mild to moderate head discomfort. - Dizziness: transient sensation of light‑headedness.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, swelling, or anaphylaxis in rare cases. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic enzyme elevation: abnormal liver function tests indicating possible liver involvement.

Before using Ambroxol Hydrochloride, consider the following precautions to ensure safe and effective therapy.

Pregnancy: consult a healthcare professional; safety data are limited. Breastfeeding: caution advised as the drug may be excreted in breast milk. Renal impairment: dose adjustment may be required in patients with reduced kidney function. Asthma: monitor for possible bronchospasm, especially in severe cases. Drug interactions: review all concomitant medications with a pharmacist or physician. Store at room temperature: keep in the original packaging, protect from moisture and heat.

Ambroxol Hydrochloride can interact with certain medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Codeine‑containing antitussives: may counteract mucolytic effect. - MAO inhibitors: increased risk of adverse reactions. - Cytotoxic chemotherapy agents: potential enhancement of toxicity.

Moderate Interactions (Monitor Closely): - Beta‑2 agonists: additive bronchodilatory effect may require monitoring. - Antihistamines: may increase sedation or dry mouth. - Antacids: may alter absorption if taken simultaneously.